XML 85 R54.htm IDEA: XBRL DOCUMENT v3.26.1
Income Taxes (Schedule of Significant Components of the Company's Deferred Tax Asset) (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Deferred taxes        
Net operating loss carry-forward $ 44,464 $ 40,755 [1]    
Capital losses 3,271 0    
Share-based compensation expense 374 351    
Capitalized research and development costs 1,742 3,103    
Other 8 10    
Deferred tax assets 49,859 44,219    
Less - valuation allowance (49,859) (44,219) $ (43,471) $ (41,195)
Net deferred tax assets, net of valuantion allowance $ 0 $ 0    
[1] This excludes capital losses of approximately $14,223 thousands for which the Company has recorded a full valuation allowance.